Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Alkem Labs shares in focus as sellers look to offload 1.5% stake via block deal
The term sheet also specifies a 90-day lock-up period on any further sale of shares by the sellers.
Stocks to Watch Today: Alkem Labs, Ola Electric, PNC Infratech, Equitas Small Finance Bank, NHPC, Anant... - Moneycontrol.com
Stocks to Watch Today: Alkem Labs, Ola Electric, PNC Infratech, Equitas Small Finance Bank, NHPC, Anant...Moneycontrol.com
Block deal launched in Alkem Laboratories, up to 1.5% stake on offer
Alkem Laboratories sees block deal for up to 1.5% stake at floor price ₹5,200 per share, Q4FY26 revenue up 14.6%. Shares of Alkem Laboratories ended lower on June 1 by 3.27% at ₹5,318 on the NSE.
Alkem Lab gains after Q4 PAT slumps 25% YoY to Rs 251 cr
Alkem Laboratories added 2.34% to Rs 5,580 after the company reported 25.11% drop in consolidated net profit to Rs 251.11 crore despite 14.62% jump in revenue from operations to Rs 3603.32 crore in Q4 March 2026 over Q4 March 2025.
Stocks to Watch today: RIL, Lupin, Wipro, Asian Paints, Ireda,Tata Elxsi
Stocks to Watch today, May 29, 2026: Ashok Leyland, Alkem Laboratories, PhysicsWallah, GMR Airports, InterGlobe Aviation, NMDC, and Glenmark Pharma are among the top stocks to remain in focus today
Alkem Laboratories consolidated net profit declines 22.69% in the March 2026 quarter
Sales rise 14.62% to Rs 3603.32 crore
Alkem Lab Q4 PAT slumps 25% YoY to Rs 251 cr
Alkem Laboratories reported 25.11% drop in consolidated net profit to Rs 251.11 crore despite 14.62% jump in revenue from operations to Rs 3603.32 crore in Q4 March 2026 over Q4 March 2025.
Alkem Labs Q4 Results: Net Profit Declines 28% As One-Time Loss Weighs; Dividend Declared — Check Record Date
Consolidate revenue of Alkem Labs advanced by 14.6% year-on-year for the three months ended March, reaching Rs 3,603 crore in comparison to Rs 3,144 crore.
US FDA finds violations at Alkem Labs’ Daman facility after 12-day inspection
The inspection was carried out over a 12-day period from April 20 to May 1. Alkem Laboratories did not provide specific details regarding the nature of the observations.
Alkem Labs CEO Vikas Gupta may exit company
Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to depart in the coming months. Gupta joined Alkem from Cipla and has a strong background in the Indian pharmaceutical market.
Alkem launches multivitamin supplement - A to Z Daily tablets
Alkem Laboratories announced the launch of A to Z Daily, an everyday multivitamin supplement for adults, for providing holistic nutritional support to the body and mind.
Belrise Expands Globally with Aerospace Acquisition | Alkem Labs Expands Manufacturing with Ujjain Project | Top Buzzing Stocks Today - Equitymaster
Belrise Expands Globally with Aerospace Acquisition | Alkem Labs Expands Manufacturing with Ujjain Project | Top Buzzing Stocks TodayEquitymaster